Nisa Investment Advisors LLC Sells 8,439 Shares of Danaher Corporation $DHR

Nisa Investment Advisors LLC trimmed its holdings in shares of Danaher Corporation (NYSE:DHRFree Report) by 4.2% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 190,579 shares of the conglomerate’s stock after selling 8,439 shares during the quarter. Nisa Investment Advisors LLC’s holdings in Danaher were worth $37,708,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also bought and sold shares of DHR. Sierra Ocean LLC lifted its stake in shares of Danaher by 116.9% during the 1st quarter. Sierra Ocean LLC now owns 141 shares of the conglomerate’s stock worth $29,000 after purchasing an additional 76 shares during the last quarter. Smallwood Wealth Investment Management LLC purchased a new stake in Danaher in the 1st quarter worth approximately $31,000. Red Tortoise LLC increased its holdings in shares of Danaher by 175.0% during the 2nd quarter. Red Tortoise LLC now owns 154 shares of the conglomerate’s stock valued at $30,000 after purchasing an additional 98 shares in the last quarter. Costello Asset Management INC purchased a new position in shares of Danaher in the 1st quarter valued at about $41,000. Finally, Ramirez Asset Management Inc. acquired a new stake in Danaher in the second quarter valued at approximately $40,000. Institutional investors own 79.05% of the company’s stock.

Analyst Upgrades and Downgrades

Several analysts have issued reports on DHR shares. Weiss Ratings restated a “hold (c-)” rating on shares of Danaher in a report on Friday. UBS Group reduced their price objective on Danaher from $240.00 to $225.00 and set a “buy” rating on the stock in a research note on Wednesday, July 23rd. Royal Bank Of Canada set a $241.00 price target on Danaher in a research report on Tuesday, September 2nd. Rothschild & Co Redburn reiterated a “neutral” rating and set a $220.00 target price (down previously from $245.00) on shares of Danaher in a research note on Wednesday, October 8th. Finally, Barclays upped their price objective on Danaher from $225.00 to $250.00 and gave the company an “overweight” rating in a research note on Wednesday. Eighteen analysts have rated the stock with a Buy rating and five have given a Hold rating to the company. Based on data from MarketBeat, Danaher presently has an average rating of “Moderate Buy” and a consensus target price of $243.39.

Check Out Our Latest Analysis on DHR

Insider Activity at Danaher

In other news, Director Teri List sold 2,778 shares of Danaher stock in a transaction dated Friday, August 22nd. The stock was sold at an average price of $211.06, for a total value of $586,324.68. Following the transaction, the director directly owned 20,751 shares of the company’s stock, valued at $4,379,706.06. The trade was a 11.81% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this link. 11.10% of the stock is currently owned by company insiders.

Danaher Stock Performance

Shares of DHR opened at $223.03 on Friday. The company has a market capitalization of $157.54 billion, a PE ratio of 45.99, a P/E/G ratio of 3.41 and a beta of 0.77. Danaher Corporation has a 52-week low of $171.00 and a 52-week high of $258.23. The company has a 50-day simple moving average of $202.73 and a 200-day simple moving average of $198.53. The company has a quick ratio of 1.22, a current ratio of 1.52 and a debt-to-equity ratio of 0.33.

Danaher (NYSE:DHRGet Free Report) last announced its quarterly earnings results on Tuesday, October 21st. The conglomerate reported $1.89 EPS for the quarter, topping the consensus estimate of $1.72 by $0.17. Danaher had a return on equity of 10.92% and a net margin of 14.44%.The business had revenue of $6.05 billion for the quarter, compared to analyst estimates of $6 billion. During the same quarter in the previous year, the company earned $1.71 EPS. The company’s quarterly revenue was up 4.4% on a year-over-year basis. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. Equities research analysts predict that Danaher Corporation will post 7.63 earnings per share for the current fiscal year.

Danaher Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, October 31st. Investors of record on Friday, September 26th will be issued a $0.32 dividend. The ex-dividend date is Friday, September 26th. This represents a $1.28 dividend on an annualized basis and a yield of 0.6%. Danaher’s dividend payout ratio (DPR) is presently 26.39%.

About Danaher

(Free Report)

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.

Further Reading

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.